Form 4: InspireMD CEO Marvin Slosman Granted Over 1.1M RSUs
Insider Transaction Report
InspireMD's CEO and President, Marvin Slosman, was granted 1,114,792 restricted stock units, vesting over three years.
Summary
- Marvin Slosman, CEO and President of InspireMD, Inc. (NSPR), acquired 1,114,792 restricted stock units (RSUs).
- The transaction date for this acquisition was January 14, 2026.
- The RSUs were acquired at a price of $0, which is typical for such grants.
- Following this transaction, Marvin Slosman beneficially owns 3,535,658 securities.
- The restricted stock units will vest in three equal annual installments, with 1/3 vesting on January 14, 2027, January 14, 2028, and January 14, 2029, contingent upon continued service.
- A Power of Attorney was filed, appointing Michael Lawless as attorney-in-fact for Marvin Slosman to handle SEC filings.
Sentiment
Score: 7
Explanation: The grant of restricted stock units to the CEO is generally a positive signal for executive alignment and retention, as it ties the executive's compensation to the company's long-term performance. It does not, however, provide direct insight into operational or financial performance.
Positives
- The grant of restricted stock units aligns the CEO's long-term interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
- This type of equity grant serves as a retention mechanism, incentivizing the CEO to remain with the company through the vesting period.
Future Outlook
The vesting schedule for the restricted stock units extends through January 2029, indicating an expectation of Marvin Slosman's continued service as CEO and President for the foreseeable future.
Industry Context
The grant of restricted stock units to a CEO is a common practice in the corporate world, particularly in the medical device or biotechnology sector where long-term incentives are used to retain key leadership and align their performance with shareholder value creation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Appointment | Marvin Slosman appointed Michael Lawless as his attorney-in-fact to prepare, execute, and submit SEC Forms ID, 3, 4, and 5 on his behalf, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934. | 01/16/2026 | This is a standard procedural measure to facilitate timely and accurate insider transaction reporting, enhancing compliance efficiency for the reporting person. |
Related Party Transactions
- The grant of 1,114,792 restricted stock units to Marvin Slosman, the CEO and President, constitutes a related party transaction as it involves compensation from the company to a key executive.
Stakeholder Impact
- Shareholders: The RSU grant aligns the CEO's financial incentives with long-term shareholder value creation, as the value of the units is tied to the company's stock price.
- Employees: The grant may signal stability in leadership, potentially impacting employee morale and confidence in the company's direction.
Next Steps
- The vesting of the restricted stock units will occur in three annual installments on January 14, 2027, January 14, 2028, and January 14, 2029, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 01/14/2026 | Date of acquisition of 1,114,792 Restricted Stock Units by Marvin Slosman. |
| 01/16/2026 | Date of signature for the Power of Attorney document. |
| 01/14/2027 | First vesting date for 1/3 of the Restricted Stock Units. |
| 01/14/2028 | Second vesting date for 1/3 of the Restricted Stock Units. |
| 01/14/2029 | Third and final vesting date for 1/3 of the Restricted Stock Units. |
Keywords
InspireMD, NSPR, Marvin Slosman, Restricted Stock Units, RSU, CEO, Executive Compensation, Insider Transaction, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.